Aortech Share Discussion Threads

[bones] 22/1/2018 22:59

Anyone into heavy reading can take a look at this discussion of replacement heart valves. AOR and Elast-Eon is buried in there somewhere but it's worth persevering to understand the subject matter. It's a complex area. I think this piece was written 5 years ago so it is possible AOR have made strides since as may many of the others seeking this holy grail of long lasting prosthetic heart valves.Https://pdfs.semanticscholar.org/9456/d30d83b55d83d843111c920138f2919f0b9f.pdf

[cocker] 22/1/2018 16:19

Yes it does, but like I said, "could go either way".

[davisc5] 22/1/2018 11:33

Gone a bit quiet, chart still looks good

[the stigologist] 18/1/2018 09:33

Is it 'ignorant' to say 'let's wait for what the knowledgeable insiders tell us' ?

[harrogate] 18/1/2018 09:21

I see you only define negative views as "hopeless ignorant speculation" not your own "positive" hopeless ignorant speculation.

[the stigologist] 18/1/2018 09:16

Only the Management know the true situation. Each contractual licence will have it's own specific terms with those particular counterparties. Being 'Monday morning' Quarterbacks on here is a futile exercise. Let them get on with it rather than spouting hopeless ignorant speculation.

[harrogate] 18/1/2018 09:06

I take back the no new licences point - apologies. The rest stands and I think anyone on here hoping for short good news will be sadly disappointed.

[the stigologist] 18/1/2018 09:01

Why not read an RNS before embarrassing yourself harrogate?

"A new revenue-generating licence has been signed and enquiries have increased markedly. "

[harrogate] 18/1/2018 08:57

mikeh30 - I suggest that you go back over the last 5+ years and read the statements. They have always been about to sign new licences with lots of people evaluating the material. Have they cancelled any other licences other than the one they gave a few years ago to a weird Latin American company.

[25october1969] 18/1/2018 08:54

The licenses are granted to companies who, in simple terms, incorporate the AOR technology into their products and then sell the products and AOR receive license fees. AOR also have an agreement with a third party who produce elast-eon for sale to third parties and AOR benefit financially from these sales. AOR have no capacity themselves to manufacture and produce no products therefore licenses terminated = no income for AOR. There should certainly be a review of existing licenses to see if greater income can be generated

It is to be hoped that the review will also identify ways of increasing AOR income by identifying existing unused/underused AOR intellectual property and putting together a strategy for bringing a product to market which incorporates that technology. It is difficult to see AOR doing this on a stand alone basis due to lack of employees and lack of financial clout

In addition, taking a product to market does not happen overnight, especially in the medical field, therefore cash is required from other sources ie license fees, to meet day to day requirements. It would be great to see new license agreements announced, for example breast enhancements, where AOR have recently got ownership of their technology back

It is hoped that the next RNS from AOR will update on these points and hopefully identify a strategy going forward which will see the clearly excellant technology owned by AOR, being monitised for the benefit of shareholders


Edit - written before i saw your post harrogate and I agree, in the main, with your comments

[mikeh30] 18/1/2018 08:51

Also using Elast-eon in the cosmetic field amongst other areas. They have recently recalled some licenses. These are the ones that can be re-assigned so yes we do know where new licenses can come from It's pretty clear from their statements

[harrogate] 18/1/2018 08:48

I am not sure why anyone thinks that suddenly lots more licences will be signed in the short term? Biomerics have the technology and it can't be brought back in house as we have no facilities, staff or expertise. We are in essence a virtual company that relies on Biomerics to promote our technology. As far as we know and I am sure it would have been trumpeted, they have signed no new licences for our material for a good while. Even when someone might be interested and are thus evaluating the material it takes years to get it applied to the product, approved and into the market and thus to start providing an income for us.
The key here as I have said for years is the heart valve - the development of synthetic heartvalves has taken off and if our technology still has validity for this market - it is nearly 20 years old now - we could get some real excitement from this. But any development of this will need cash and it will be all about the structure and dilution involved in that inevitable fundraise.

[mikeh30] 18/1/2018 08:36

""There are currently a number of companies evaluating Elast-Eon(TM) which if succesful may lead to other licences.""

[cocker] 18/1/2018 08:22

Exactly Roy. This is the path to take & hopefully more to follow.

[mustau] 18/1/2018 08:12

Just a question, would this not generate more income?

[25october1969] 18/1/2018 08:04

mustau -Why would they terminate licenes, which is their only income stream, and bring back in house?

[mustau] 18/1/2018 07:47

Normally internal reviews tend to have a guideline of 3/6 months. Unless they started before dec 17, conclusion in March.
Not expecting a fund raise but this is aim!

[cocker] 18/1/2018 07:41

Why March? . I anticipate that news will come asap with details of how to best utilise AOR's intellectual property. My only concern is that when it does come, its not accompanied with some sort of fund raise at a reduced price to give AOR a cash injection.

[mustau] 17/1/2018 21:37

Not expecting anything until at least March, hopefully review concluded.
What chance of terminating licences and bring back in-house?

[verulamium] 17/1/2018 21:10

Not sure it's worth the wait for a price 5p or so better. If there's a decent RNS it'll be 11th Dec all over again and very hard to buy a decent quantity. I topped up this afternoon (nice of them to drop it for me) - that's me done for now.

[k1ngkonggb] 17/1/2018 19:45

Yep, it might go a tad lower to test mid to late 30's but then a great buying opp.

[mustau] 17/1/2018 19:43

Without news only one way unfortunately.

[cocker] 17/1/2018 15:30

Chart still intact but could go either way big time.

[mustau] 15/1/2018 17:49

I’ll be happy with the tens first!!
Let’s hsve some news.